Glucocorticoids and beta-cell function

Area of Science:

• Endocrinology
• Metabolic Research
• Cell Biology

Background:

• Glucocorticoids (GCs) are key regulators of carbohydrate metabolism, known to induce insulin resistance (IR) and impair glucose tolerance.
• While GCs counteract insulin and affect hepatic gluconeogenesis, their direct impact on pancreatic beta cells remains incompletely understood.
• Excess GCs in humans are linked to IR, impaired glucose tolerance, and diabetes, despite elevated insulin levels.

Purpose of the Study:

• To review and synthesize the current understanding of the direct effects of glucocorticoids on pancreatic beta cell function.
• To elucidate the mechanisms by which GCs influence insulin secretion and glucose sensing in beta cells.
• To address discrepancies in reported findings regarding GC effects on beta cells.

Main Methods:

• Review of existing literature on glucocorticoid action in carbohydrate metabolism and beta cell function.
• Analysis of human clinical data and rodent models of glucocorticoid excess.
• Examination of in vitro studies investigating direct GC effects on beta cell secretion and molecular pathways.

Main Results:

• GC excess is associated with insulin resistance, impaired glucose-stimulated insulin secretion (GSIS), and altered beta cell mass in rodent models.
• In vitro studies predominantly show an inhibitory effect of GCs on insulin secretion, potentially via effects on glucose sensing, insulin gene transcription, and exocytosis.
• Some studies and transgenic models suggest that GCs might enhance beta cell secretory capacity, highlighting conflicting findings.

Conclusions:

• Glucocorticoids play a significant role in carbohydrate balance, with direct impacts on beta cell function contributing to glucose homeostasis dysregulation.
• Observed discrepancies in GC effects on beta cells likely stem from variations in experimental designs and models.
• Further understanding of GC-beta cell interactions is crucial for developing clinical strategies for metabolic disorders.